Shiseido China cosmetic sales fell 25%, the overall performance pressure-onavo protect

Shiseido Chinese cosmetic sales fell 25%, the overall performance pressure Beijing daily (reporter Li Duo Wang Qian) Shiseido cosmetics performance in China did not appear big improvement. Japan’s largest beauty products group, Shiseido Corporation (Shiseido Co. Ltd.) the day before the release of the 2015 fiscal year earnings are expected to show that 12.6% to 763 billion 58 million yen in the Japanese domestic market revenue growth, according to a fixed exchange rate increase of 7.8%. For the Chinese market, Shiseido annual revenue was flat, the cosmetics department, including ZA, PURE&MILD and other brands, balancing performance downturn, annual sales fell 25%; luxury sector including Shiseido, NARS, key to skin brand revenue growth of 31%. In the face of weak cosmetic formats, Shiseido said that the low-end market is facing fierce competition, including the group’s own management, management issues. It is understood that Shiseido Greater China revenue increased by 2%, of which the Hongkong market increased by 10%. Last November, Shiseido appointed Kentaro Fujiwara, general manager of the Strategic Development Department of the former group, as the president of the Chinese market, and ShigeruTakano, the former president of China’s market. Affected by the downward pressure of China’s market economy, Shiseido’s performance has been under considerable pressure in recent years. In fiscal year 2014, Shiseido’s sales in China amounted to 114 billion 800 million yen, and at fixed exchange rate, revenue fell by 4.8%, exceeding 3.2% of Japan’s domestic market, becoming the largest decline of Shiseido in the world’s major markets. Fiscal year 2015 Shiseido operating profit increased 77.4% to 37 billion 660 million yen, net profit of 23 billion 210 million yen. Previously, Shiseido group has lowered sales expectations in fiscal year 2015, from 765 billion yen down to 760 billion yen. In order to prepare for the restructuring and transformation, Shiseido has taken the initiative to reduce the distributors orders in China, so as to avoid excessive inventory. At present, sales in China account for about 17%. Enter Sina Financial shares] discussion

资生堂中国彩妆全年销售跌25% 整体业绩承压   北京商报讯(记者 李铎 王茜)资生堂在华的化妆品业绩并未出现大的起色。日本最大美容产品集团资生堂株式会社(Shiseido Co.,Ltd.)日前发布的2015财年财报预期显示,日本本土市场收入增长12.6%至7630.58亿日元,按固定汇率增长7.8%。对于中国市场,资生堂收入全年持平,其中化妆品部门,包括悠莱、姬芮、泊美等品牌业绩表现低迷,全年销售下跌25%;奢侈品部门包括资生堂、NARS、肌肤之钥等品牌收入则增长31%。   面对彩妆业态的疲软表现,资生堂方面表示,中低端市场面临激烈竞争,包括本集团自身管理、经营方面的问题。据了解,资生堂大中华区收入共增长2%,其中香港市场增长10%。去年11月,资生堂任命原集团企业战略发展部门总经理Kentaro Fujiwara为中国市场总裁,原中国市场总裁ShigeruTakano卸任。   受中国市场经济下行压力影响,资生堂的业绩在近年承受着相当大的压力。2014财年,资生堂中国区销售额为1148亿日元,按固定汇率计算,收入下跌了4.8%,超过日本本土市场3.2%的跌幅,成为资生堂在世界各大市场中跌幅最大的区域。   2015财年资生堂营业利润增长77.4%至376.6亿日元,净利润232.1亿日元。此前资生堂集团曾下调2015财年的销售预期,从此前的7650亿日元降至7600亿日元。为了筹备重组转型,资生堂已经主动减少了在中国地区的分销商订单,以避免出现过多库存。目前,在华业务的销售占比约为17%左右。 进入【新浪财经股吧】讨论相关的主题文章: